Software-driven medical technology developer Brainlab has secured 510(k) clearance from US Food and Drug Administration (FDA) for two software modules for radiation oncologists and neurosurgeons.

The company’s Adaptive Hybrid Surgery and Automatic Brain Metastases Planning software, part of the Brainlab Elements portfolio, builds on the company’s aim to enhance access and consistency of patient care.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Brainlab president Stefan Vilsmeier said: "FDA clearance of these software modules marks a critical milestone in the Brainlab vision of indication-specific tools.

"We expect their capabilities, efficiency and usability to help change the way certain life-threatening diseases are treated."

"A complete set of automated tools will allow adjuvant radiosurgery analysis at any time, while planning and performing a surgical resection."

Adaptive Hybrid Surgery was designed to help physicians balance surgical risk with radiosurgical toxicity for multi-disciplinary treatment of skull-base tumours.

See Also:

In addition, a complete set of automated tools will allow adjuvant radiosurgery analysis at any time, while planning and performing a surgical resection.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The Elements Intraoperative Structure Update will gather residual tumour volumes, based on points acquired inside the resection cavity, whereas an intuitive traffic light display offers comprehensive information regarding tumour coverage and critical dose constraints for calculated treatment plans.

Designed to consistently and rapidly generate radiosurgery plans for efficient treatment of multiple metastases, Automatic Brain Metastasis Planning software enables clinicians to plan and treat multiple brain metastases with time and dose efficiencies, while helping to minimise exposure to healthy surrounding tissue.